<qa>  What is the primary outcome of the study variable?The study population will be pregnant women 18-50 years, 34-39 weeks of fetal gestational age with preeclampsia The primary outcome of the study variable will be the difference in the vascular tone in isolated perfused cotyledons. The secondary outcomes will be: i the degree of MBG binding to DIGIBIND at different time points following DIGIBIND administration, ii the effect of DIGIBIND on the activity of NaK-ATPase in erythrocytes, and iii the ex vivo effect of DIGIBIND on the vascular tone in the isolated placental lobes. 